Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (Southern, 159297) experienced a decline of 2.63% on January 30, with a trading volume of 74.33 million yuan [1] - The fund's shares increased by 35 million, bringing the total shares to 2 billion, with a net asset value of 1.639 billion yuan [1] - Over the past 20 trading days, the fund's shares have increased by 183 million [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs, adjusted for valuation exchange rates [1] - The fund is managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -18.16%, while the return over the past month is 2.78% [1]
1月30日港股通创新药ETF南方（159297）份额增加3500.00万份
Xin Lang Cai Jing·2026-02-02 01:15